BKYI Stock Risk & Deep Value Analysis
BIO-Key International Inc
Industrials • Security & Protection Services
DVR Score
out of 10
What You Need to Know About BKYI Stock
We analyzed BIO-Key International Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran BKYI through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
BKYI Risk Analysis & Red Flags
What Could Go Wrong
The preliminary Q1 2026 guidance for revenue growth and cash flow positivity might not materialize or be sustainable, leading to a resumption of cash burn and further stock devaluation. The pending 2025 audit also introduces significant uncertainty and potential for adverse findings that could severely impact investor confidence.
Risk Matrix
Overall
Aggressive
Financial
High
Market
High
Competitive
High
Execution
High
Regulatory
Medium
Red Flags
- ⚠
2025 audit not yet complete, posing a risk of accounting irregularities or delayed filings.
- ⚠
Declining gross margin (77.5% in 2025 from 81.4% in 2024).
- ⚠
Persistent net losses and negative operating margins historically.
- ⚠
Revenue decline for FY2025 and Q4 2025 despite Q1 2026 preliminary growth guidance.
Upcoming Risk Events
- 📅
Q1 2026 earnings miss, particularly on revenue guidance or cash flow positivity
- 📅
Failure to complete the 2025 audit cleanly or adverse audit findings
- 📅
Increased competitive pressure leading to further market share erosion or margin compression
When to Reconsider
- 🚪
Exit if Q1 2026 earnings fail to confirm cash flow positivity and significant revenue growth.
- 🚪
Sell if gross margin falls below 75% for two consecutive quarters.
- 🚪
Exit if the 2025 audit reveals material weaknesses or accounting issues.
Unlock BKYI Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does BIO-Key International Inc (BKYI) Do?
Market Cap
$6.73M
Sector
Industrials
Industry
Security & Protection Services
Employees
41
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education sectors in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, services, and cloud host, as well as windows device authentication through IAM platform. The company's solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and civil and large-scale ID infrastructure solutions that develop finger-based biometric technology. Further, the company offers finger scanners for enterprise and consumer markets under SideSwipe, PIV Pro, EcoID II, and SidePass brand names; and fingerprint readers. Additionally, it provides identity and access management, user multi-factor authentication, and privilege entitlement and access control solutions. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.
Visit BIO-Key International Inc WebsiteInvestment Thesis
BIO-key is a high-risk micro-cap positioned for a potential turnaround, banking on its preliminary Q1 2026 guidance for significant revenue growth and a critical shift to cash flow positivity in the biometric identity and access management (IAM) market. Success in executing this pivot, particularly within its niche defense and financial sectors, could drive substantial re-rating from its current distressed valuation, albeit with significant inherent risks.
Is BKYI Stock Undervalued?
Unlock the full AI analysis for BKYI
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
BKYI Price Targets & Strategy
12-Month Target
$2.00
Bull Case
$4.00
Bear Case
$0.15
Valuation Basis
Based on 1 analyst's price target, implying a 4.28x P/S multiple on projected FY26 revenue of $8.8M (annualized Q1 2026 guidance).
Entry Strategy
Dollar-cost average between $0.45-$0.60, watching for confirmation of Q1 2026 positive cash flow. Avoid significant upfront investment due to high risk.
Exit Strategy
Take 50% profit at $2.00. Re-evaluate at $4.00 based on sustained profitability and growth. Implement a hard stop-loss at $0.30 if financial performance deteriorates or cash burn resumes.
Portfolio Allocation
1-3% for aggressive risk tolerance, only as a highly speculative bet within a diversified portfolio.
Price Targets & Strategy
Upgrade to Premium for price targets and entry/exit strategies
Is BKYI Financially Healthy?
Valuation
P/E Ratio
-0.65
Price/Sales
0.62
Balance Sheet
Total Debt
$1.09M
Cash & Equivalents
$2.70M
Cash Flow
Operating Cash Flow
-$4.66M
Free Cash Flow
-$4.67M
Does BKYI Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Eroding (due to overall revenue decline and competitive pressure), but potential for stabilization/expansion if Q1 2026 results are strong and consistent.
Moat Sources
3 Identified
The moat's durability is highly dependent on BIO-key's ability to retain its large user base, continue innovating its biometric and IAM solutions, and successfully execute on its targeted sector strategies against larger, better-funded competitors.
Moat Erosion Risks
- •Intense competition from larger, more comprehensive IAM providers.
- •Customer churn if new competitors offer superior or cheaper solutions.
- •Dependence on a few large contracts/renewals in niche sectors.
BKYI Competitive Moat Analysis
Sign up to see competitive advantages
BKYI Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Limited discussion, likely Neutral/Low Bullish among retail investors given micro-cap status and recent performance.
Institutional Sentiment
Neutral to slightly Negative given low institutional ownership (26.51%) and no specific recent upgrades/downgrades or significant buying indicated.
Insider Activity (Form 4)
No specific Form 4 filings reported in last 90 days (January 1 to March 31, 2026).
Options Flow
Normal options activity (no specific unusual activity reported in the intelligence).
Earnings Intelligence
Next Earnings
Estimated early-May 2026 (for Q1 2026, following preliminary guidance)
Surprise Probability
High (given the significant preliminary guidance for Q1 2026 after a Q4 2025 EPS miss, expectations are volatile).
Historical Earnings Pattern
Volatile, susceptible to significant stock price movements based on actual results versus guidance, as evidenced by a 10.2% pre-market drop after Q4 2025 revenue decline.
Key Metrics to Watch
Competitive Position
Top Competitor
Not provided in research, but likely larger, more established cybersecurity or IAM providers (e.g., Okta, Ping Identity).
Market Share Trend
Historically stable to losing given revenue declines, but potential for gaining in niche defense/financial segments if Q1 2026 guidance holds.
Valuation vs Peers
Cannot perform a robust comparison without specific peer data, but BKYI's current revenue and market cap indicate a significantly smaller scale and higher risk profile.
Competitive Advantages
- •Established PortalGuard solution with 40M+ users (potential for switching costs)
- •Traction in specific sectors like foreign defense and financial institutions
- •Growing hardware demand (>100% in 2025) indicating some specialized product fit
Market Intelligence
Get sentiment, earnings intel, and peer analysis with Premium
What Could Drive BKYI Stock Higher?
Near-Term (0-6 months)
- •Q1 2026 Earnings Report (expected soon after preliminary guidance confirmation)
- •Confirmation of Q1 2026 cash flow positivity and significant revenue growth
Medium-Term (6-18 months)
- •Continued momentum and additional contract wins in defense and financial sectors
- •Successful integration and adoption of PortalGuard 7.0 leading to sustained revenue growth
- •Achieving consistent quarterly profitability
Long-Term (18+ months)
- •Establishing a clear market leadership position in niche biometric IAM segments
- •Demonstrated scalability of hardware and software solutions leading to exponential growth
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for BKYI?
- ✓
Confirmation of Q1 2026 cash flow positive results and sustained revenue growth in subsequent quarters.
- ✓
Successful and clean resolution of the 2025 audit findings.
- ✓
Significant new customer acquisitions or larger contract renewals beyond current Q1 announcements.
Bull Case Analysis
See what could go right with Premium
Competing with BKYI
See how BIO-Key International Inc compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
BIO-Key International Inc BKYI | $6.7M | 1.5 | -0.7 | $6.9M | 0.0% | 0.0% | |
Caterpillar Inc CAT | $407.0B | 0.1 | 45.8 | $64.8B | 13.1% | 4.3% | Compare → |
General Electric Co GE | $306.2B | 0.1 | 35.9 | $45.9B | 20.0% | 18.0% | Compare → |
Honeywell International Inc HON | $134.7B | 1.5 | 29.8 | $37.4B | 11.4% | 3.6% | Compare → |
RTX Corp RTX | — | 0.1 | 5.0 | $88.6B | 7.6% | 0.0% | Compare → |
United Parcel Service Inc UPS | $81.3B | 0.1 | 14.3 | — | — | — | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
FAQ
What is the DVR Score for BIO-Key International Inc (BKYI)?
As of April 1, 2026, BIO-Key International Inc has a DVR Score of 1.5 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of BIO-Key International Inc?
BIO-Key International Inc's market capitalization is approximately $6.7M. The company operates in the Industrials sector within the Security & Protection Services industry.
What ticker symbol does BIO-Key International Inc use?
BKYI is the ticker symbol for BIO-Key International Inc. The company trades on the NCM.
What is the risk level for BKYI stock?
Our analysis rates BIO-Key International Inc's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of BKYI?
BIO-Key International Inc currently has a price-to-earnings (P/E) ratio of -0.7. This is below the market average, which could indicate the stock is undervalued or facing headwinds.
Is BIO-Key International Inc's revenue growing?
BIO-Key International Inc has reported revenue growth of 0.0%. Revenue has been declining, which warrants closer examination.
Is BKYI stock profitable?
BIO-Key International Inc has a profit margin of 0.0%. The company is currently unprofitable.
How often is the BKYI DVR analysis updated?
Our AI-powered analysis of BIO-Key International Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 1, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for BKYI (BIO-Key International Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.